PBH vs. IPAR, HLF, USNA, NUS, NATR, MED, VERU, EL, ITCI, and UTHR
Should you be buying Prestige Consumer Healthcare stock or one of its competitors? The main competitors of Prestige Consumer Healthcare include Inter Parfums (IPAR), Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Veru (VERU), Estée Lauder Companies (EL), Intra-Cellular Therapies (ITCI), and United Therapeutics (UTHR).
Prestige Consumer Healthcare vs.
Prestige Consumer Healthcare (NYSE:PBH) and Inter Parfums (NASDAQ:IPAR) are both mid-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, community ranking, valuation, dividends, institutional ownership, profitability, analyst recommendations and media sentiment.
Prestige Consumer Healthcare has a beta of 0.44, meaning that its stock price is 56% less volatile than the S&P 500. Comparatively, Inter Parfums has a beta of 1.33, meaning that its stock price is 33% more volatile than the S&P 500.
99.9% of Prestige Consumer Healthcare shares are owned by institutional investors. Comparatively, 55.6% of Inter Parfums shares are owned by institutional investors. 1.6% of Prestige Consumer Healthcare shares are owned by company insiders. Comparatively, 43.9% of Inter Parfums shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Prestige Consumer Healthcare has higher earnings, but lower revenue than Inter Parfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Inter Parfums, indicating that it is currently the more affordable of the two stocks.
Prestige Consumer Healthcare has a net margin of 19.13% compared to Inter Parfums' net margin of 10.60%. Inter Parfums' return on equity of 16.34% beat Prestige Consumer Healthcare's return on equity.
Prestige Consumer Healthcare pays an annual dividend of $1.90 per share and has a dividend yield of 2.2%. Inter Parfums pays an annual dividend of $3.20 per share and has a dividend yield of 2.5%. Prestige Consumer Healthcare pays out 44.3% of its earnings in the form of a dividend. Inter Parfums pays out 62.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Inter Parfums has increased its dividend for 4 consecutive years. Inter Parfums is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Prestige Consumer Healthcare received 27 more outperform votes than Inter Parfums when rated by MarketBeat users. Likewise, 70.14% of users gave Prestige Consumer Healthcare an outperform vote while only 65.24% of users gave Inter Parfums an outperform vote.
Prestige Consumer Healthcare currently has a consensus target price of $93.33, suggesting a potential upside of 9.78%. Inter Parfums has a consensus target price of $157.60, suggesting a potential upside of 20.78%. Given Inter Parfums' stronger consensus rating and higher possible upside, analysts plainly believe Inter Parfums is more favorable than Prestige Consumer Healthcare.
In the previous week, Inter Parfums had 4 more articles in the media than Prestige Consumer Healthcare. MarketBeat recorded 11 mentions for Inter Parfums and 7 mentions for Prestige Consumer Healthcare. Prestige Consumer Healthcare's average media sentiment score of 1.29 beat Inter Parfums' score of 0.93 indicating that Prestige Consumer Healthcare is being referred to more favorably in the media.
Summary
Inter Parfums beats Prestige Consumer Healthcare on 13 of the 21 factors compared between the two stocks.
Get Prestige Consumer Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Prestige Consumer Healthcare Competitors List
Related Companies and Tools
This page (NYSE:PBH) was last updated on 5/22/2025 by MarketBeat.com Staff